EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer - Wikidata - wikimedia - TriplyDB

EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer

EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer

http://www.wikidata.org/entity/Q58760097

about

EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer

http://www.wikidata.org/entity/Q58760097

description

article publié dans la revue scientifique PLoS ONE

@fr

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in PLoS ONE

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

EGFR signaling suppresses type ...... retion in head and neck cancer

@en

EGFR signaling suppresses type ...... retion in head and neck cancer

@nl

type

label

EGFR signaling suppresses type ...... retion in head and neck cancer

@en

EGFR signaling suppresses type ...... retion in head and neck cancer

@nl

prefLabel

EGFR signaling suppresses type ...... retion in head and neck cancer

@en

EGFR signaling suppresses type ...... retion in head and neck cancer

@nl

P1433

Q58760097-2553C715-75F2-451A-AD51-B18718A59EE9

P1476

Q58760097-E6FBC39A-7832-419E-B0EE-EB59AC1921B2

P2093

Q58760097-1B38EBB5-3248-42DC-ACE2-EAFC3BC6E25E

Q58760097-6199DEEC-6104-4C78-881D-F443FD29D403

Q58760097-78B1C7A2-3A6B-456A-85DB-7D3F60E1AF28

Q58760097-80C475BC-66F3-48CA-9CDE-E812F3B956D4

Q58760097-D2674748-B6DD-4FC3-BB0E-5F0A39AE3A66

Q58760097-E91F3368-40DA-45FE-AC71-5EB90A0349FE

P2860

Q58760097-024A7D32-8A41-4B8F-88B3-7808D75A9D8E

Q58760097-057C4B4E-5882-48FD-9D12-A48C7E4EB611

Q58760097-1609D346-9266-40E8-9593-31B73FDA98B6

Q58760097-1C4D3E33-4942-4CAE-9CA5-6431BD044C87

Q58760097-1F14A3D6-2945-420A-83AA-75791E829B2A

Q58760097-202D4DB1-86DB-4889-9C24-4BBE47C6E29B

Q58760097-25488F07-1E8D-4101-9264-DA0BC800EE51

Q58760097-2AFFA6B7-FDE4-4DAF-8D14-4536D468DA09

Q58760097-2BC6CAE0-6A90-4113-A7BC-03F32760E750

Q58760097-2D3B116F-9BDB-4D98-89C4-94A07663D3A2

P304

Q58760097-682EB64F-6903-421D-92BA-80902DF8EA8A

P31

Q58760097-D655BB7E-FC74-4066-BA91-9BB57C49FA49

P356

Q58760097-04C7C2C3-CE13-4A93-B0C6-F04B5A0E6FF9

P407

Q58760097-CCB36E56-AC59-4677-91BB-3D59726E92D7

P433

Q58760097-73B095BE-C728-4C9E-B594-703FCF0E8827

P478

Q58760097-CC2D8794-1463-405A-9E3B-8AD3D42EB983

P50

Q58760097-B5DD463C-6335-4463-9841-10F071F12CE7

P577

Q58760097-174956EA-297F-43AB-813B-927BC97CF066

P698

Q58760097-BE5EEF33-92E0-46EC-8A5D-9D7B55D10870

P932

Q58760097-43101069-1F8B-49AE-983D-E01073EFDF24

P356

JOURNAL.PONE.0203402

P1433

P1476

EGFR signaling suppresses type ...... retion in head and neck cancer

@en

P2093

Fernando Concha-Benavente

http://www.w3.org/2001/XMLSchema#string

Ilina Ehsan

http://www.w3.org/2001/XMLSchema#string

Marij J P Welters

http://www.w3.org/2001/XMLSchema#string

Robert L Ferris

http://www.w3.org/2001/XMLSchema#string

Saskia J A M Santegoets

http://www.w3.org/2001/XMLSchema#string

Wenbo Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Human papillomavirus and survival of patients with oropharyngeal cancer.

The quest to overcome resistance to EGFR-targeted therapies in cancer.

EGFR activation suppresses respiratory virus-induced IRF1-dependent CXCL10 production

BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer

Overexpression of EGFR in head and neck squamous cell carcinoma is associated with inactivation of SH3GL2 and CDC25A genes.

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation.

CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.

Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation.

STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients.

P304

e0203402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0203402

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Sjoerd H van der Burg

P577

2018-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30192802

http://www.w3.org/2001/XMLSchema#string

P932

6128559

http://www.w3.org/2001/XMLSchema#string